Perceiv AI
Perceiv AI is an AI-driven precision medicine company specializing in a multimodal prognostic platform to forecast disease progression in age-related disorders, primarily Alzheimer's disease. Their platform, featuring the AD-Px™ prognostic engine, leverages diverse data sources including imaging, genetic, phenotypic, molecular, and clinical variables to precisely target subgroups within heterogeneous populations. This enables improved patient care for physicians and accelerates drug development for pharmaceutical companies by optimizing clinical trials and reducing screen failure rates. The company has received multiple awards and certifications such as ISO 27001 and HIPAA compliance, and is recognized for increasing statistical power in early Alzheimer's clinical trials. Perceiv AI operates with a SaaS business model, serving pharmaceutical companies and clinical researchers, and is supported by strategic investors and partnerships including JLABS Johnson & Johnson and Merck.
Perceiv AI
Perceiv AI is an AI-driven precision medicine company specializing in a multimodal prognostic platform to forecast disease progression in age-related disorders, primarily Alzheimer's disease. Their platform, featuring the AD-Px™ prognostic engine, leverages diverse data sources including imaging, genetic, phenotypic, molecular, and clinical variables to precisely target subgroups within heterogeneous populations. This enables improved patient care for physicians and accelerates drug development for pharmaceutical companies by optimizing clinical trials and reducing screen failure rates. The company has received multiple awards and certifications such as ISO 27001 and HIPAA compliance, and is recognized for increasing statistical power in early Alzheimer's clinical trials. Perceiv AI operates with a SaaS business model, serving pharmaceutical companies and clinical researchers, and is supported by strategic investors and partnerships including JLABS Johnson & Johnson and Merck.